In HCC, lncRNA HULC/miR-383-5p/VAMP2 axis promoted the protective autophagy and malignant progression of HCC cells and inhibited the chemosensitivity of oxaliplatin (Li et al., 2021). Here, HULC is linked to hepatocellular carcinoma.